Outcomes4Me is a founding member of CancerX, an initiative of the Cancer Moonshot Learn more >

/ Thought Leadership

Empowering you through knowledge.

Browse our resources to feel more empowered about making informed decisions, whether you’re a patient, oncology care provider, or work in life sciences.

Articles

Aromatase inhibitors (AIs). Such as anastrozole, exemestane, and letrozole. Selective estrogen receptor modulators (SERMs). Such...
Lisa Morere— MSN, APRN, ANP-BC—is the Clinical Lead at Outcomes4Me and is a board certified...
Alongside being a member of the Outcomes4Me team, Suzanne is also a breast cancer survivor....
At the recent 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, the DESTINY-Breast04 trial...
Age at diagnosis Tumor size (T) Nodal status (N) Tumor grade Years survived since initial...
There’s no one-size-fits-all approach to a breast cancer diagnosis. Each individual has different needs when...

Other Resources